Fibulin2 is a good diagnostic and prognostic indicator for sepsis

Area of Science:

• Biomarker discovery
• Clinical diagnostics
• Sepsis research

Background:

• Sepsis is a critical condition with high mortality.
• Early sepsis intervention is crucial for patient outcomes.
• A need exists for reliable diagnostic and prognostic indicators.

Purpose of the Study:

• To evaluate Fibulin2 as a diagnostic marker for sepsis.
• To assess Fibulin2's prognostic capability in sepsis patients.
• To compare Fibulin2 with existing sepsis biomarkers.

Main Methods:

• Plasma Fibulin2 levels measured by ELISA in emergency department patients.
• Diagnostic performance assessed using Receiver Operating Characteristic (ROC) curves.
• Comparison with C-reactive protein, procalcitonin, WBC, NEU%, and D-dimer.

Main Results:

• Fibulin2 levels were significantly higher in sepsis patients.
• Fibulin2 outperformed CRP, PCT, WBC, NEU%, and D-dimer in sepsis diagnosis.
• Fibulin2 levels correlated with septic shock severity and predicted 28-day mortality.

Conclusions:

• Fibulin2 demonstrates potential as a diagnostic biomarker for sepsis.
• Fibulin2 may serve as a prognostic indicator for sepsis outcomes.
• Fibulin2 could be a valuable tool in emergency department sepsis management.